Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Umbilical Cord Blood Test Can Detect Early Sepsis in Preterm Infants

By LabMedica International staff writers
Posted on 23 Jun 2025

Diagnosing early onset sepsis (EOS) in preterm infants is particularly difficult due to the lack of specific clinical signs, leading to widespread use of antibiotics while awaiting culture results. More...

Despite negative cultures, approximately 25% of very low birth weight newborns are continued on antibiotics under the presumption of infection. Now, researchers have identified specific proteins in umbilical cord blood that can signal systemic inflammation triggered by infection, offering a new, objective, and noninvasive method to diagnose EOS more accurately and reduce unnecessary antibiotic use.

The solution was developed by scientists from Ann & Robert H. Lurie Children's Hospital of Chicago (Chicago, IL, USA) who published their findings in JCI Insight. Their research focused on preterm newborns and aimed to identify reliable markers of EOS by examining umbilical cord blood collected at birth—a sample that provides a snapshot of the baby’s immune status at delivery. The method hinges on detecting specific proteins in the cord blood that reflect an acute immune response to infection. These biomarkers act as indicators of systemic inflammation, a key feature of EOS. In addition to identifying these proteins, the researchers also developed a machine learning-based diagnostic algorithm that integrates both biomarker data and known clinical risk factors to predict EOS with greater accuracy.

The study revealed that cord blood biomarker results can be processed and made available within 24 hours, allowing physicians to make more informed decisions early on. This timely information helps rule out sepsis confidently and discontinue antibiotics where unnecessary. Given that nearly 78% of very low birth weight infants currently receive antibiotics at birth, the new tool could significantly reduce unwarranted treatment and its associated risks. In practice, the approach offers several advantages. It provides an objective diagnostic aid in a condition often diagnosed based on suspicion alone, reduces prolonged antibiotic exposure, and ultimately lowers the risk of microbiome disruption, immune dysregulation, and other long-term health effects. By facilitating quicker and more precise diagnosis, the cord blood biomarker test and its associated algorithm may improve care standards for some of the most vulnerable newborns.

 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gastrointestinal Panel
Xpert® GI Panel
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.